{"id":"https://openalex.org/W4362489205","doi":"https://doi.org/10.1158/1535-7163.c.6543109","title":"Data from Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation","display_name":"Data from Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362489205","doi":"https://doi.org/10.1158/1535-7163.c.6543109"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6543109","doi":"https://doi.org/10.1158/1535-7163.c.6543109","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6543109","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6543109","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062595689","display_name":"Caroline von Achenbach","orcid":"https://orcid.org/0000-0002-6788-5259","observed_orcids":["https://orcid.org/0000-0002-6788-5259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline von Achenbach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001849164","display_name":"Manuela Silginer","orcid":"https://orcid.org/0000-0003-2538-1244","observed_orcids":["https://orcid.org/0000-0003-2538-1244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manuela Silginer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031973170","display_name":"Vincent Blot","orcid":"https://orcid.org/0009-0003-4429-512X","observed_orcids":["https://orcid.org/0009-0003-4429-512X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent Blot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073603294","display_name":"William A. Weiss","orcid":"https://orcid.org/0000-0003-2230-9132","observed_orcids":["https://orcid.org/0000-0003-2230-9132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William A. Weiss","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2230-9132","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5017177249","display_name":"Michael Weller","orcid":"https://orcid.org/0000-0002-1748-174X","observed_orcids":["https://orcid.org/0000-0002-1748-174X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Weller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abt-414","display_name":"ABT-414","score":0.9919999837875366},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.8539999723434448},{"id":"https://openalex.org/keywords/egfrviii","display_name":"EGFRvIII","score":0.9860000014305115},{"id":"https://openalex.org/keywords/egfr-phosphorylation","display_name":"EGFR phosphorylation","score":0.7710000276565552},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8650000095367432},{"id":"https://openalex.org/keywords/monomethyl-auristatin-f","display_name":"monomethyl auristatin F","score":0.9459999799728394},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/glioma-cell-death","display_name":"glioma cell death","score":0.5419999957084656},{"id":"https://openalex.org/keywords/drug-sensitization","display_name":"drug sensitization","score":0.4230000078678131}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6916372776031494},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5953636765480042},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5930574536323547},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.5791528820991516},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5171307921409607},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4996368885040283},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.44784867763519287},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3662853240966797},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30410143733024597},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2873813509941101},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.22334548830986023},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.208017498254776},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.17392483353614807},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14303672313690186},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07356241345405579},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6543109","doi":"https://doi.org/10.1158/1535-7163.c.6543109","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6543109","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6543109","doi":"https://doi.org/10.1158/1535-7163.c.6543109","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6543109","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3023849184","https://openalex.org/W2986221179","https://openalex.org/W3215170032","https://openalex.org/W2766544064","https://openalex.org/W2996622009","https://openalex.org/W4415381368","https://openalex.org/W4362493159","https://openalex.org/W2290428590","https://openalex.org/W2900078196","https://openalex.org/W2889815745"],"abstract_inverted_index":{"Abstract":[0],"Glioblastomas":[1],"commonly":[2],"(40%)":[3],"exhibit":[4],"epidermal":[5],"growth":[6],"factor":[7],"receptor":[8],"(EGFR)":[9],"amplification;":[10],"half":[11],"of":[12,25,65,105,110,120,141,149,152,190,205,216,229],"these":[13],"tumors":[14,138],"carry":[15],"the":[16,66,203,206],"EGFRvIII":[17,51,101,111,142,187],"deletion":[18,24],"variant":[19],"characterized":[20],"by":[21],"an":[22,60],"in-frame":[23],"exons":[26],"2\u20137,":[27],"resulting":[28],"in":[29,42,89,122,125,130,239],"constitutive":[30],"EGFR":[31,34,49,88,99,121,153,162,167,185,200,208,221,232],"activation.":[32],"Although":[33],"tyrosine":[35,222],"kinase":[36,164,223],"inhibitors":[37,165,224],"had":[38],"only":[39],"modest":[40],"effects":[41],"glioblastoma,":[43],"novel":[44],"therapeutic":[45],"agents":[46],"targeting":[47],"amplified":[48],"or":[50,100,160,186],"continue":[52],"to":[53,91,102,114,128,158,161,175,195,198,243],"be":[54,92],"developed.":[55],"Depatuxizumab":[56],"mafodotin":[57],"(ABT-414)":[58],"is":[59,145],"EGFR-targeting":[61,217],"antibody\u2013drug":[62,218],"conjugate":[63],"consisting":[64],"mAb":[67,191],"806":[68,192],"and":[69,80,124,136,170,193],"a":[70,226],"toxic":[71],"payload,":[72],"monomethyl":[73],"auristatin":[74],"F.":[75],"Because":[76],"glioma":[77,96,181],"cell":[78,83,107,178,241],"lines":[79],"patient-derived":[81],"glioma-initiating":[82],"models":[84],"expressed":[85],"too":[86],"little":[87],"vitro":[90,123],"ABT-414\u2013sensitive,":[93],"we":[94],"generated":[95],"sublines":[97],"overexpressing":[98,183],"explore":[103],"determinants":[104],"ABT-414\u2013induced":[106,177],"death.":[108],"Overexpression":[109],"induces":[112],"sensitization":[113,242],"ABT-414":[115,129,212],"more":[116],"readily":[117],"than":[118,235],"overexpression":[119],"vivo.":[126],"Exposure":[127],"vivo":[131],"eliminated":[132],"EGFRvIII-expressing":[133],"tumor":[134],"cells,":[135],"recurrent":[137],"were":[139],"devoid":[140,151],"expression.":[143,154],"There":[144],"no":[146],"bystander":[147],"killing":[148],"cells":[150,182],"Surprisingly,":[155],"either":[156],"exposure":[157],"EGF":[159],"tyrosin":[163],"reduce":[166],"protein":[168],"levels":[169],"are":[171],"thus":[172],"not":[173],"strategies":[174],"promote":[176],"killing.":[179],"Furthermore,":[180],"kinase-dead":[184],"retain":[188],"binding":[189],"sensitivity":[194],"ABT-414,":[196],"allowing":[197],"dissociate":[199],"phosphorylation":[201,236],"from":[202],"emergence":[204],"\u201cactive\u201d":[207],"conformation":[209],"required":[210],"for":[211],"binding.":[213],"The":[214],"combination":[215],"conjugates":[219],"with":[220],"carries":[225],"high":[227],"risk":[228],"failure.":[230],"Promoting":[231],"expression":[233],"rather":[234],"should":[237],"result":[238],"glioblastoma":[240],"ABT-414.":[244]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}